The role of constitutively activated STAT3 in B16 melanoma cells
Open Access
- 1 January 2010
- journal article
- research article
- Published by Taylor & Francis in International Journal of Interferon, Cytokine and Mediator Research
- Vol. 2 (2) , 1-7
Abstract
The role of constitutively activated STAT3 in B16 melanoma cells Chuan He Yang1, Meiyun Fan1, Andrzej T Slominski1, Junming Yue2, Lawrence M Pfeffer11Department of Pathology and Laboratory Medicine, 2Department of Physiology, University of Tennessee Health Science Center and the Center for Cancer Research, Memphis, TN, USA Constitutively activated STAT3 is found frequently in a wide variety of human tumors, including melanoma. Moreover, constitutive STAT3 activation actively participates in tumor formation and progression, making STAT3 an attractive target for cancer therapy. We report here that in murine B16 melanoma cells, which have been previously shown to express constitutively active STAT3, the expression of a mutant form of STAT3 with the canonical tyrosine phosphorylation site (residue 705) mutated to phenylanaine has dominant-negative properties (STAT3-DN). STAT3-DN inhibits STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity. Most importantly, STAT3-DN expression in B16 cells inhibits their invasiveness, as well as their melanogenesis by down-regulation of tyrosinase mRNA and protein expression as well as tyrosinase activity. These results suggest that STAT3 signaling plays a critical role in regulating melanoma behavior, and may represent a druggable target for melanoma therapy.Keywords: STAT3, melanoma, invasion, tyrosinase, melanogenesisKeywords
This publication has 31 references indexed in Scilit:
- A lymph node metastatic mouse model reveals alterations of metastasis‐related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell lineCancer, 2002
- The Stat family in cytokine signalingCurrent Opinion in Cell Biology, 2001
- Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexesOncogene, 2000
- STAT signaling in the pathogenesis and treatment of leukemiasOncogene, 2000
- The biology of Stat4 and Stat6Oncogene, 2000
- Roles of STAT3 defined by tissue-specific gene targetingOncogene, 2000
- Physiological significance of STAT proteins: investigations through gene disruption in vivoCellular and Molecular Life Sciences, 1999
- Biochemical Control of Melanogenesis and Melanosomal OrganizationJournal of Investigative Dermatology Symposium Proceedings, 1999
- Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma CellsImmunity, 1999
- Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathwayCell, 1994